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Abstract
Gap junctions are critical for the propagation of action potentials in the heart. Many autosomal
dominant Cx40 mutations have been linked to atrial fibrillation (AF) and have showed GJ
impairments. However, others such as L221I and V85I showed apparently no GJ impairments.
Cells expressing L221I or V85I alone showed increased propidium iodide uptake, which was
also the case for cells co-expressing L221I and wildtype Cx40, suggesting increased
hemichannel opening probability. A novel AF-linked Cx45 mutant (M235L) was found to
impair GJ function. These alterations in hemichannel or GJ function might play a role in
promoting AF. The atria express Cx40 and Cx43 abundantly with low levels of Cx45, and may
form heterotypic GJs. However, wildtype heterotypic Cx40/Cx43 or Cx40/Cx45 GJs were not
functional, unless a designed Cx40 structural variant (D55N) was used, suggesting these
heterotypic GJs are unlikely to mediate coupling in the native heart.
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Chapter 1: Introduction
1.1

Gap junction channels

Direct communication between apposed cells is mediated by intercellular channels known
as gap junctions (GJs). These channels allow the passage of ions and various molecules
less than 1 kDa in size and are important for a number of physiological processes such as
development, metabolic cooperation, and tissue synchronicity (Evans and Martin, 2002).
The connexin (Cx) is an integral membrane protein which constitutes the GJ channel. 21
genes in the human genome and 20 in the mouse encode connexins, and each connexin is
named according to its predicted molecular weight in kDa from Cx23 to Cx62 (Sohl and
Willecke, 2004). Connexins are predicted to have a topological structure of four
transmembrane domains (TM1-TM4), two extracellular loops (E1-E2), one cytoplasmic
loop (CL), and intracellular amino and carboxyl terminals (NT and CT, respectively) (Fig.
1.1A). These connexins oligomerize into hexamers to form the hemichannel (HC) (or
connexon). Based on the connexin arrangement, these HCs can be homomeric or
heteromeric (Evans and Martin, 2002).
HCs exist in nearly all cells that express connexins (Saez et al., 2010), and they should not
be confused with pannexins, which are similar in topological structure (Sosinsky et al.,
2011). When docked to form a full GJ channel, these docked HCs (or GJ channel) open to
allow intercellular communication between cells. When undocked, however, HCs usually
remain closed especially in cultured cells in resting conditions, but this may not be
reflective of those in vivo, as various amounts of stimuli are present (Saez et al., 2010). The
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open probability of HCs can be increased by various means such as membrane
depolarization, mechanical stimulation, increased intracellular calcium ([Ca2+]i), or
decreased extracellular calcium ([Ca2+]o (Bennett et al., 2003; De Vuyst et al., 2006;
Goodenough and Paul, 2003; Tong et al., 2007). When opened, HCs may appear to play a
role in paracrine signaling due to their ability to leak out ions and signalling molecules
such as ATP, Na+, PGE2, and Ca2+ (Fig. 1.1B) (Kar et al., 2012). Unitary conductance of
HCs (γHC) also tend to be approximately twice that of unitary transjunctional conductance
(γj) as demonstrated in Cx26 (Gonzalez et al., 2006).
In order to form a GJ channel, each neighbouring cell contributes at least a HC, which dock
head-to-head through non-covalent interactions, including hydrogen bonds. Hydrogen
bonds are critical in docking as a reduction in the number of hydrogen bonds prevent
docking and function altogether (Gong et al., 2013). As most cells express more than one
connexin isoform, connexins can oligomerize in different combinations or arrangements
as they form HCs. Based on connexin composition, the HCs can be classified as homomeric
or heteromeric, and the GJ channels can be classified as homotypic or heterotypic (Fig.
1.1C) (Evans and Martin, 2002). Due to the differences in amino acid sequences of
connexins, not all homomeric heterotypic combinations produce functional GJ channels
(Bai and Wang, 2014). It is interesting to understand which residues are important for
heterotypic docking of non-compatible connexins.
As previously mentioned, GJ channels provide electrical coupling between cells, which is
critical for tissue synchronicity, such as in the heart. GJ channel function can be influenced
by changes in potential difference between the cytoplasms of coupled cell-pairs
(transjunctional voltage, Vj) and the absolute voltage between internal and external
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environments of the cell (transmembrane voltage, Vm). While Gj of all vertebrate GJ
channels is sensitive to Vj, some GJ channels are influenced by both Vj and Vm (Gonzalez
et al., 2007). Maximal Gj for homotypic GJ channels tends to occur when Vj is equal to
zero. Moreover, at increasing positive and negative Vj, symmetric decreases to low
conductance values (Gmin) occur to form a bell shape as demonstrated in amphibian
blastomeres (Harris et al., 1981). The Vj-gating properties can be described by the
Boltzmann function for each Vj polarity (Gonzalez et al., 2007). GJs of different connexins
show different Vj-gating properties, which may be important for their unique function.
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Figure 1.1 Topological structures of the connexin, hemichannels, and gap junction
channels. A. A topological structure of a connexin, an integral membrane protein, which
has four transmembrane domains (TM1-TM4), two extracellular domains (E1-E2), one
cytoplasmic loop (CL), and intracellular amino and carboxyl terminals (NT and CT,
respectively). B. A connexin hemichannel. A hexamer of connexin proteins, which can
allow the passage of a variety of ions, metabolites, and signaling molecules. C. The four
types of gap junction channels based on different possible connexin rearrangements. The
nomenclature on hemichannels and GJ channels are indicated below each channel.
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1.2

Cardiac connexins

Gap junctions are required for the rapid conduction of electrical signals for synchronized
contractions in the heart. Under physiological conditions, action potentials originate from
the sinoatrial (SA) node, which propagates to the atria, and slows down in the
atrioventricular (AV) node. From there, it travels through the Purkinje-His conduction
system and finally from the apex of the heart to the ventricles. Any disruption in the rapid
propagation of action potentials in the heart may lead to complications which may result
in ventricular and atrial fibrillation (AF), as examples (Hagendorff et al., 1999).
Three major connexins, located in specific regions of the heart, are responsible for the
heart’s electrical synchronicity (Fig. 1.2). Connexin45 (Cx45) resides in the nodal regions
and in the Purkinje-His conduction system, including the upper and lower bundle branches,
of the heart. Connexin40 (Cx40) resides in the atria and in the Purkinje-His conduction
system including the upper and lower bundle branches, and connexin43 (Cx43) resides
primarily in the atria and ventricles with some expression in the Purkinje fibres and lower
bundle branches. (Severs et al., 2008). My thesis will focus on two of these cardiac
connexins, namely Cx40 and Cx45.
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Figure 1.2 Typical expression of the three major cardiac connexins: Cx40, Cx43,
and Cx45. (Adapted from Severs et al., 2008)
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1.2.1

Connexin40

Cx40 is one of the three major connexins expressed in cardiac tissue. It is encoded by the
gap junction protein alpha 5 (GJA5) gene on chromosome 1 in humans (Willecke et al.,
1990). It has also been shown to be expressed in other tissues such as smooth muscle cells
and endothelial cells (Gabriels and Paul, 1998; Little et al., 1995).
Cx40 is highly expressed in the atria and tends to co-localize with Cx43 (Gemel et al.,
2014). The possibility of the existence of heteromeric Cx40 and Cx43 HCs have also been
postulated through the use of co-immunoprecipitation. This introduces a lot of possible
variability in GJ function as multiple single channel current amplitudes were observed
through functional studies (He et al., 1999). This provides a contrast to homomeric
heterotypic Cx40 and Cx43 GJ channels as studies show conflicting results in regards to
the presence of function, which may be due to docking compatibility (Bruzzone et al.,
1993; Lin et al., 2014; Valiunas et al., 2000).
The importance of Cx40 has been shown in a number of animal models (Chaldoupi et al.,
2009). In ECG recordings of Cx40 knockout (KO) mice there were no differences in heart
rate, but interval prolongation in each tested ECG parameter was observed, which suggests
a decrease in conduction velocity. In addition, arrhythmia was also observed in these mice,
which highlights the importance of the presence of Cx40 in cardiac tissue for fast and
proper electrical conduction (Hagendorff et al., 1999; Kirchhoff et al., 1998).
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1.2.2

Connexin45

Cx45 is one of the principal connexins expressed in the heart, and is expressed in specific
regions such as the nodal tissues and conduction system. It is encoded by the gap junction
protein gamma 1 (GJC1) gene on chromosome 17 (Kanter et al., 1994). Cx45 can also be
found in a variety of tissues such as the lung, brain, and skin (Hennemann et al., 1992).
In the early stages of the fetus, Cx45 is highly expressed and plays a major role in heart
development. It has been shown that Cx45 knockout mice died as early as E9.5, as after
the initiation of vasculogenesis, blood vessel formation and smooth muscle layer
development in the arteries were not able to proceed (Kruger et al., 2000). In adult mice,
however, cardiomyocyte-restricted Cx45 KOs were viable but showed AV nodal
conduction impairment. This was shown by a prolonged PQ interval on the
electrocardiogram and prolonged AH (atria to His bundle) interval on the intracardiac
electrogram, which highlights its importance in fetal development, especially in the heart
(Frank et al., 2012).
1.3

Atrial fibrillation

Atrial fibrillation (AF) is a sustained cardiac arrhythmia which affects more than 2.5
million Americans and 350 000 Canadians (Fuster et al., 2006). This number is expected
to almost triple by the year 2050, which will lead to an increased burden on the health care
system (Go et al., 2001). In most cases, AF is believed to be secondary to systemic
disorders or heart diseases since it will lead to structural changes in the heart which promote
AF. These diseases include: diabetes, hypertension, coronary artery disease, and
myocardial infarction (Benjamin et al., 1998). In approximately 30% of cases, however,
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AF occurs on its own without association with cardiovascular diseases; this is called
idiopathic or lone AF. The study of lone AF provides insight into the possible etiology and
pathophysiology of AF without confounding factors that may be present when systemic or
cardiovascular disease exists.
Patients with AF exhibit an irregular and erratic P-wave pattern on an electrocardiogram,
which translates into improper atrial conduction, and subsequently, contraction.
Consequently, this may affect the electrical conduction to the ventricles, which would
negatively affect ventricular contraction as shown by a reduced QRS-complex (Wakili et
al., 2011). These patients would have a six-fold increase in risk for embolic stroke and a
two-fold increase in risk for death (Wolf et al., 1991).
1.4

Rationale and Objectives

GJA5, the gene encoding Cx40, has been suspected to be an important player responsible
for lone AF. In a previous study, 4 out of 15 patients had mutations in GJA5 and showed
early onset of lone AF (Gollob et al., 2006). Two recent germline GJA5 mutants, L221I
and V85I, were discovered by Yang and colleagues, which were shown to be autosomal
dominant with 100% penetrance (Fig. 1.3) (Yang et al., 2010). In our lab, we have
demonstrated that L221I and V85I showed similar Gj as wildtype Cx40, which was unusual
since most, if not all, Cx mutants show GJ impairment (Fig 1.4). When we assessed the
potential hemichannel activity of these mutants through the dye uptake assay, we saw
pronounced hemichannel activity. Since these mutants are autosomal dominant, it suggests
that one allele is enough to trigger AF. In the atria, Cx40 and Cx43 are co-expressed and
provide the possibility that these mutants interact with either Cx40 or Cx43. It will be
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interesting to determine whether or not any differences in hemichannel activity exist when
these mutants are present with wildtype Cx40 or Cx43.
As previously mentioned, differences in certain amino acid residues in the extracellular
domains may be responsible for the incompatibility in heterotypic docking observed
between different Cxs. Controversial data exists for the docking of Cx40 and Cx43, so it
may be interesting to determine which residue(s) will be responsible for compatibility. In
addition, previous studies on the heterotypic docking of mouse Cx40 and Cx45 showed
coupling (Rackauskas et al., 2007). However, there were no studies on the heterotypic
docking between human Cx40 and Cx45. This might be important for action potential
propagation from the SA node to the atria and from the AV node through the ventricular
conduction system, which is enriched with both of these connexins.
In summary, the objectives of this study is to characterize the hemichannel function of
Cx40 mutants co-expressed with wildtype Cx40 or Cx43, and subsequently understand
their possible role(s) in atrial fibrillation; characterize the GJ channel function of the Cx45
mutant and understand their possible role(s) in atrial fibrillation; and functionally study the
role of the extracellular domains in the docking compatibility of cardiac connexins.
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A

L221I

B

V85I

Figure 1.3 Pedigrees of the two Cx40 mutants. In the case of both (A) L221I and (B)
V85I atrial fibrillation (denoted by the coloured shapes) co-segregated with each mutant
(denoted by +) regardless of male (square) or female (circle). The probands are identified
by the arrow. (Adapted from Yang et al., 2010)
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Figure 1.4 Topological structure of Cx40 with known atrial fibrillation-linked
mutants. Germline mutations are denoted in red and somatic mutations are denoted in
green. (Adapted from Bai, 2014)
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1.5

Hypotheses

1. I hypothesize that the co-expression of the AF-linked Cx40 mutants, L221I and V85I,
with wildtype Cx40 or Cx43 will show an increased function compared to Cx40
hemichannels or heteromeric wildtype Cx40/Cx43 hemichannels.
2. I hypothesize that the Cx45 mutant, M235L will alter GJ function in homotypic GJs or
heterotypic GJs with Cx45 (or Cx43). I also hypothesize that this mutant will show a
difference in hemichannel activity.
3. I hypothesize that engineered variant of Cx40, D55N, will increase GJ coupling and GJ
conductance in the docking of Cx43 and Cx45 compared to wildtype Cx40.
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Chapter 2: Functional study with propidium iodide uptake on cells co-expressing
atrial fibrillation-linked connexin40 mutants with connexin40 or connexin43
2.1 Introduction
Direct cell-cell communication via gap junctions (GJs) is critical for the rapid propagation
of action potentials in the heart to synchronize the beating of the atria and ventricles. Gap
junction channels are formed by a head-to-head docking of two hemichannels (HCs). HCs
are hexamers of integral membrane proteins called connexins (Cxs). HCs composed of the
same connexin isoform are homomeric and HCs composed of different connexin isoform
are heteromeric (Goodenough and Paul, 2009). There are 21 human and 20 mouse genes
that encode connexins (Sohl and Willecke, 2004). My study is focussed on Cx40 and Cx43,
which are the major connexins expressed in the heart. Cx40 is expressed in the atria and in
the ventricular conduction system including the Purkinje-His bundle and the upper and
lower bundle branches. Cx43 is the most abundant connexin in the heart and it is expressed
in the atria, ventricles, and in the Purkinje fibres and lower bundle branches. As the atria
expresses both Cx40 and Cx43, it presents the possibility of forming homomeric or
heteromeric HCs (Severs et al., 2008). The possibility of forming heteromeric Cx40-Cx43
HCs have been explored through co-immunoprecipitation and functional studies. Coimmunoprecipitation experiments were performed in vascular smooth muscle cells, which
co-express Cx40 and Cx43. Anti-Cx40 antibodies were able to co-immunoprecipitate both
Cx40 and Cx43, and vice versa. This would suggest that the interaction between Cx40 and
Cx43 may be the formation of heteromeric HCs. To support this further, functional studies
were performed on cell-pairs co-expressing Cx40 and Cx43, which showed many new
levels of single channel conductances that were not observed when expressing Cx40 or
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Cx43 alone. These experiments would suggest that Cx40 and Cx43 may be capable in
forming heteromeric HCs (He et al., 1999).

Atrial fibrillation (AF) is a sustained cardiac arrhythmia which affects nearly 2.5 million
Americans and is expected to almost triple by 2050. This will increase the burden on the
healthcare system (Fuster et al., 2006; Go et al., 2001). Patients with AF are twice as likely
to experience death and six times more likely to have embolic stroke compared to those
without AF (Wolf et al., 1991). In 70% of cases, AF is secondary to systemic disorders and
diseases such as hypertension, diabetes, myocardial infarction, or other cardiomyopathies
(Benjamin et al., 1998). For the remainder of cases, AF is the primary illness and is termed
“idiopathic” or lone AF. Lone AF can be triggered by changes in genes whose protein
products are critical in atrial function.
Mutations in GJA5, the gene for encoding Cx40, were found to be linked to AF. In vitro
studies of these mutations showed impaired protein trafficking and/or GJ coupling (Gollob
et al., 2006; Sun et al., 2013). These studies provide a glimpse into the importance of proper
GJ channel function to maintain proper physiological functions. In 2010, Yang and
colleagues discovered two missense mutations in the gene for Cx40 which led to mutations
L221I and V85I. Based on the pedigrees of the probands, these mutations were shown to
be autosomal dominantly inherited with 100% penetrance as the members of the families
who carry either mutation in one of their two Cx40 alleles developed an early onset of AF
(Fig. 1.3) (Yang et al., 2010).
Our lab has studied the GJ function for the two Cx40 mutants, L221I and V85I, and found
that it was similar to wildtype Cx40 (Sun et al., 2014). This was unusual as most, if not all,
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known connexin mutants show some level of impairment of GJ channel function compared
to wildtype (Bai, 2014). As these mutations apparently did not alter gap junction function,
it was possible that hemichannel function was affected. Experiments with propidium iodide
(PI) uptake revealed that these mutants appeared to have an increased PI uptake compared
with wildtype Cx40 (Sun et al., 2014), indicating these mutants may have an increase in
hemichannel function. Since these are autosomal dominantly inherited mutants, one allele
would encode the mutant and the other the wildtype. Therefore, the co-expression of Cx40
mutants with wildtype Cx40 (or Cx43) is possible to occur in vivo. We hypothesize that
the co-expression of the AF-linked Cx40 mutants, L221I and V85I, with wildtype Cx40 or
Cx43 will show an increased PI uptake compared to cells expressing Cx40 alone or Cx40
co-expressed with Cx43.
My data showed that PI uptake was significantly reduced by the gap junction blockers,
flufenamic acid and mefloquine, which indicate that the PI uptake was likely mediated by
GJ HCs. In addition, the PI uptake of L221I co-expressed with Cx40 was significantly
increased compared to the doubly-expressed wildtype Cx40. However, V85I co-expressed
with Cx40 or both Cx40 mutants co-expressed with Cx43 showed no significant difference
in PI uptake compared to their wildtype controls.
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2.2 Methods
2.2.1 Plasmid construction
Both Cx40 mutants, L221I and V85I, and human Cx40-IRES2-EGFP or Cx43-IRES2EGFP genes were subcloned into a bidirectional vector (pBI-CMV1) (Fig. 2.1) (Clontech
Laboratories Inc., Mountain View, CA) at the following sites:
MCSI: IRES2-EGFP

Sites: BamHI and NotI

Cx43-IRES2-EGFP

Sites: NheI and NotI

Cx40-IRES2-EGFP

Sites: NheI and NotI

MCSII:

Cx40

Sites: EcoRI and BglII

L221I

Sites: EcoRI and BglII

V85I

Sites: EcoRI and BglII

The human Cx40-IRES-GFP, Cx43-IRES-GFP and Cx26-GFP constructs were created as
previously described (Sun et al., 2013; Thomas et al., 2004). The non-fusion GFP-tagged
(V85I-IRES-GFP and L221I-IRES-GFP) constructs were generated by the QuikChange
site directed mutagenesis kit (Stratagene, La Jolla, CA) on the respective template with the
following primers and were sequenced to prevent any errors:
V85I Forward
Reverse
L221I Forward
Reverse

5’-CAGATCATCTTCATCTCCACGCCCT-3’
5’-AGGGCGTGGAGATGAAGATGATCTG-3’
5’-CTGTCCCTCCTCATTAGCCTGGCTG-3’
5’-CAGCCAGGCTAATGAGGAGGGACAG-3’
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MCS I

MCS II

Mutant

Cx40/43

Vector

IRES
GFP
Figure 2.1 Schematic of bidirectional vector. Two proteins of interest can be expressed
simultaneously (Clontech Laboratories, Inc., 2009). In this case, the mutant and wildtype
connexins are co-expressed to mimic the predicted expression patterns in the atria.
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2.2.2 Cell culture and transfection
HeLa (human cervical carcinoma, American Type Culture Collection, Manassas, VA) cells
were grown in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Burlington,
ON) containing 4.5 g/L D-(+)-glucose, 584 mg/L L-glutamine, 110 mg/L sodium pyruvate,
10% fetal bovine serum and 1% penicillin and streptomycin, in an incubator with 5% CO2
at 37ºC. HeLa cells were plated at 40–60% confluence on 35 mm petri dishes 24 hours
before transfection. For each transfection, HeLa cells were incubated with 1.0 µg of a
cDNA construct and 2 µL of X-tremeGENE HP DNA transfection reagent (Roche,
Mississauga, ON) in Opti-MEM I + GlutaMAX-I medium supplemented with HEPES and
2.4 g/L sodium bicarbonate (Invitrogen) for 5 hours. Medium was then changed back to
DMEM and cells were used for dye uptake assays approximately 24 hours after
transfection.
2.2.3 Dye uptake assay
The dye uptake assay with propidium iodide (PI) was used to assess the hemichannel
function of Cx40 and mutants with untagged GFP. HeLa cells were cultured at a low
density to allow for isolated, single cells to be transiently transfected as described above.
The cells were washed with regular extracellular solution (ECS) (also known as divalent
cation-containing ECS, DCC-ECS) (in mM): 142 NaCl, 5.4 KCl, 1.4 MgCl2, 2 CaCl2, 10
HEPES and 25 D-(+)-Glucose. The pH and osmolarity of ECS was adjusted to 7.35 and
298 mOsm, respectively. The cells were then washed with divalent cation free-ECS (DCFECS), which contains no Ca2+ or Mg2+ and 2 mM EGTA to chelate the remaining ambient
divalent cations. The cells were incubated in DCF-ECS-containing PI (150 µM) at 37ºC
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for 15-20 minutes to facilitate PI-uptake. After incubation, the cells were washed three
times with DCC-ECS and the percentage of transfected cells (green with GFP) showing
PI-uptake was measured under a fluorescent microscope (DMIRE2, Leica). Cells in pairs
and clusters were excluded from measurement to avoid errors produced by gap junctions.
Negative and positive controls (GFP and Cx26-GFP transfected cells, respectively) and the
various incubation conditions (e.g. with hemichannel blockers flufenamic acid [50 µM] or
mefloquine [25 µM]) were indicated in each experiment. For each experiment
approximately 40–50 cells were counted to obtain a percentage of PI-uptake. The bar
graphs were generated with 4–12 transfections.
2.2.4 Statistical analysis
Student’s t-test or one-way ANOVA followed by Newman-Keuls post-test were used to
compare two or multiple groups of data, respectively, as specified. Statistical significance
is denoted with asterisks (*, p < 0.05; **, p < 0.01; or ***, p < 0.001) on the graphs. The
data presented on the graphs are expressed as mean ± standard error of the mean (SEM).
Unless specified, all data were obtained from at least three independent experiments.
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2.3 Results
2.3.1 Gap junction channel blockers, flufenamic acid and mefloquine, reduce
hemichannel mediated propidium iodide uptake
A significant difference in the percentage of HeLa cells showing PI uptake in cells
expressing either L221I (75.1 ± 2.9%, N = 12; p < 0.001) or V85I (34.2 ± 3.5%, N = 12; p
< 0.001), compared with cells expressing Cx40 (5.0 ± 0.8%, N = 8). Two known gap
junction channel blockers, flufenamic acid (FFA) and mefloquine (MFQ), were used to
determine whether or not PI uptake was mediated by hemichannels. HeLa cells transiently
transfected with L221I bathed in DCF-ECS with either FFA (7.7 ± 2.6%, N = 6; p < 0.001)
or MFQ (21.4 ± 4.4%, N = 6; p < 0.001) and PI showed a significant decrease in the
percentage of cells showing PI uptake compared to cells expressing L221I (75.1 ± 2.9%,
N = 12) without blockers. HeLa cells transiently transfected with V85I bathed in DCFECS with either FFA (1.6 ± 0.8%, N = 6; p < 0.001) or MFQ (7.4 ± 2.5%, N = 6; p < 0.001)
and PI also showed a significant decrease in the percentage of cells showing PI uptake
compared to cells expressing V85I (34.2 ± 3.5%, N = 12) without blockers (Figure 2.2 and
2.3).
These data show that both blockers FFA and MFQ were able to attenuate PI uptake in cells
expressing either L221I or V85I. This would suggest that the observed PI uptake seen in
cells expressing L221I or V85I were mediated by connexin HCs.
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Figure 2.2 Representative fluorescent images of PI uptake of HeLa cells expressing
various constructs in different DCF conditions. First column shows cells transfected
with genes of interest in green from GFP. Second column shows any visible PI uptake in
red. Third column shows the overlay of both first and second columns. Fourth column
shows the phase images of the cells. Cells expressing L221I showed prominent PI uptake
in DCF. Both gap junction channel blockers, FFA (50 µM) and MFQ (25 µM), reduced PI
uptake for HeLa cells expressing L221I. Cells expressing V85I in DCF showed PI uptake.
Both FFA and MFQ reduced PI uptake of cells expressing V85I. Scale bars in each series
of images represent 20 µm.
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Figure 2.3 Graph summarizing PI uptake of HeLa cells expressing L221I or V85I in
DCF conditions. The PI uptake of cells expressing L221I in both FFA (7.7 ± 2.6%, N =
6) and MFQ (21.4 ± 4.4%, N = 6) in DCF showed a significant reduction in PI uptake
compared to L221I without blockers (75.1 ± 2.9%, N = 12). The PI uptake of cells
expressing V85I in both FFA (1.6 ± 0.8%, N = 6) and MFQ (7.4 ± 2.5%, N = 6) in DCF
showed a significant reduction in PI uptake compared to V85I without blockers (75.1 ±
2.9%, N = 12). Negative control not shown. The number of transfections (N) are denoted
by the numbers on the bars. Statistical significance is denoted by asterisks: ***, p < 0.001.
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2.3.2 Co-expression of connexin40 mutant, L221I, and connexin40 showed an
increased propidium iodide uptake
Both AF-linked Cx40 mutants, L221I and V85I, are autosomal dominant with one gene
allele containing the mutation and the other with wildtype Cx40. To study the effects of
the co-expression of mutant and wildtype Cx40 we used a bidirectional vector capable of
expressing the mutant, either L221I or V85I, and the wildtype Cx40 with untagged GFP as
a reporter (via IRES-GFP plasmid).
Transiently transfected HeLa cells were bathed in DCF-ECS to promote PI uptake. Both
Cx40 mutants, L221I (61.1 ± 6.5%, N = 6) and V85I (21.5 ± 5.0%, N = 6) showed PI
uptake, with the positive control, Cx26-GFP (95.9 ± 1.7%, N = 9) working as expected.
The hemichannel function of Cx40 mutants co-expressed with Cx40 was assessed by using
PI uptake (Figure 2.4). When these mutants were co-expressed with Cx40, a significant
increase in PI uptake for L221I (9.0 ± 2.1%, N = 7; p < 0.01, Student’s t-test) was seen
compared to cells doubly expressing wildtype Cx40 (1.3 ± 0.9%, N = 5), whereas no
difference was seen for V85I (3.3 ± 1.4%, N = 8, Student’s t-test). When the PI uptake of
cells co-expressing L221I or V85I with wildtype Cx40 are compared to cells expressing
mutants alone, significant decreases in PI uptake were observed. PI uptake of cells coexpressing L221 with Cx40 (9.0 ± 2.1%, N = 7) showed a reduced PI uptake compared to
cells expressing only L221I (61.1 ± 6.5%, N = 6; p < 0.001, Student’s t-test). The same has
also been observed for V85I as the PI uptake of cells co-expressing V85I and Cx40 (3.3 ±
1.4%, N = 8) showed a reduced PI uptake compared to cells expressing V85I alone (21.5
± 5.0%, N = 6; p < 0.001, Student’s t-test) (Figure 2.5).
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Figure 2.4 Representative images of PI uptake of HeLa cells co-expressing Cx40
mutants, L221I or V85I, with wildtype Cx40 in DCF conditions. Column 1 shows cells
transfected with different constructs. Names in the color green denote the side of the
bidirectional vector expressing GFP via IRES. Column 2 shows cells with PI uptake in red.
Column 3 shows the overlay of both first and second columns. Column 4 shows the phase
contrast images of HeLa cells. Cx40 mutants, L221 and V85I, co-expressed with wildtype
Cx40 showed little PI uptake. Scale bars in each series of images represent 20 µm.
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Figure 2.5 Graph summarizing PI uptake of HeLa cells co-expressing Cx40 mutants,
L221I or V85I, with wildtype Cx40 in DCF-ECS. Cells co-expressing L221I and Cx40
(9.0 ± 2.1%, N = 7) showed an increase PI uptake compared to cells doubly expressing
Cx40 (1.3 ± 0.9%, N = 5). However, no significance increase in PI uptake was observed
for cells co-expressing V85I and Cx40 compared to wildtype. A reduced PI uptake was
observed in cells co-expressing L221 with Cx40 (9.0 ± 2.1%, N = 7) compared with cells
expressing only L221I (61.1 ± 6.5%, N = 6; p < 0.001, Student’s t-test). The PI uptake of
cells co-expressing V85I and Cx40 (3.3 ± 1.4%, N = 8) showed a reduced PI uptake
compared to cells expressing V85I alone (21.5 ± 5.0%, N = 6; p < 0.001, Student’s t-test).
The number of transfections (N) is denoted by the numbers on the bars. Statistical
significance is denoted by asterisks: **, p < 0.01
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2.3.3 Connexin40 mutants co-expressed with connexin43 showed similar propidium
iodide uptake to co-expressed wildtype connexin40 and connexin43
As the atria expresses both Cx40 and Cx43 it grants the possibility of Cx40 and Cx43
interacting with one another. Thus, it is possible for these AF-linked Cx40 mutants to
interact with Cx43 to form heteromeric hemichannels.
For our experiment, hemichannel function of AF-linked Cx40 mutants co-expressed with
Cx43 was assessed by using PI uptake in DCF conditions (Figure 2.6A). The positive and
negative controls, Cx26 and GFP, respectively, were the same as the previous experiment
involving the co-expression of AF-linked Cx40 mutants with wildtype Cx40, since it was
performed at the same time. PI uptake for both L221I co-expressed with Cx43 (18.7 ±
2.4%, N = 4) and V85I co-expressed with Cx43 (18.0 ± 5.1%, N = 4) showed no significant
difference compared with the wildtype: Cx40 co-expressed with Cx43 (20.3 ± 2.6%, N =
4; p > 0.05, Student’s t-test) (Figure 2.6B).
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Figure 2.6 PI uptake of HeLa cells co-expressing Cx40 mutants, L221I or V85I, with
wildtype Cx43 in DCF conditions. (A) Representative PI uptake images of cells coexpressing Cx40 mutants, L221I or V85I, with Cx43. Little PI uptake was observed.
Connexin names in the colour green denote the side of the bidirectional vector expressing
GFP via IRES. Column 1 shows GFP fluorescence. Column 2 shows cells with PI uptake
in red. Column 3 is an overlay which is the combination of green and red fluorescence.
Column 4 displays a phase contrast image of HeLa cells. Scale bars in each series of images
are represented as 20 µm. (B) Graph summarizing PI uptake of cells co-expressing Cx40
mutants, L221I or V85I, with Cx43. No significant difference was observed comparing
cells co-expressing Cx40 mutants with Cx43 with the wildtype. The number of
transfections (N) is denoted by the numbers on the bars.
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2.4 Discussion
To verify if PI uptake was mediated through connexin hemichannels, two connexin
hemichannel blockers, FFA and MFQ, were used. Both blockers, FFA and MFQ, were
shown to be effective in reducing PI uptake of cells expressing either AF-linked Cx40
mutants, L221I or V85I. These data support the idea that PI uptake is mediated through
connexin hemichannels. This portion of the study has already been published (Sun et al.,
2014).
To assess the hemichannel function of co-expressed AF-linked Cx40 mutants, L221I or
V85I, with Cx40 or Cx43, a bidirectional vector with a predicted 1:1 expression ratio was
used to express both mutant and wildtype at the same time. This was done in an attempt to
mimic native atrial tissue cells in the patients, i.e. the cardiomyocytes of the atria express
both Cx40 and Cx43 (Severs et al., 2001). Both of these mutants linked to early onset of
AF in the families in an autosomal dominant way and AF co-segregated with both mutant
alleles with 100% penetrance, which indicated that one Cx40 mutant allele was sufficient
to lead to an early onset of atrial fibrillation as displayed in the pedigree (Figure 1.3) (Yang
et al., 2010).
Each mutant was expressed with Cx40 or Cx43 in HeLa cells in the DCF condition, and
assessed with PI for dye uptake. HeLa cells were incubated in PI for 15 minutes to allow
for saturation because it is thought that hemichannels have two gates; slow loop-gating or
fast Vj-gating, and both must be opened in order for PI to pass through (Bukauskas and
Verselis, 2004). By assessing the hemichannel function of different heteromeric
hemichannels formed by either L221I or V85I with Cx40 or Cx43 with the dye uptake
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assay, L221I/Cx40 hemichannels showed an increased permeability to PI which would be
an apparent gain-of-function compared to Cx40/Cx40 hemichannels. This partially
supports the hypothesis that the co-expression of AF-linked Cx40 mutants with Cx40 or
Cx43 will show an increase in hemichannel function.
When the Cx40 mutants, L221I and V85I, were co-expressed with Cx40 or Cx43,
reductions in PI uptake compared to L221I or V85I alone were observed. When L221I was
co-expressed with Cx40 or Cx43, a significant reduction in PI uptake was observed
compared to L221I alone. In addition, when V85I was co-expressed with Cx40, a
significant reduction in PI uptake was observed compared to V85I alone. However, there
was no difference in PI uptake between V85I alone and when V85I was co-expressed with
Cx43. It was previously suggested that Cx40 and Cx43 were able to form heteromeric
hemichannels due to co-immunoprecipitation and GJ channel function data (He et al.,
1999). The PI uptake data obtained would also suggest that Cx40 and Cx43 may interact
with each other, instead of independently, to affect hemichannel function.
Our experiments only used the dye uptake assay in the DCF condition to assess
hemichannel function. This condition was successful in assessing hemichannel function
when the mutants were expressed alone. However in this case, it may be possible that L221I
or V85I co-expressed with Cx40 or Cx43 are more sensitive to other stimuli such as
changes in membrane potential, mechanical stimulation, or intracellular Ca2+, which have
also been shown to increase hemichannel opening probability (Bennett et al., 2003; De
Vuyst et al., 2006; Goodenough and Paul, 2003). It is also possible that multiple conditions
need to be employed in order to obtain a robust response.

37

Even though the hypothesis that the co-expression of Cx40 mutants with wildtype Cx40 or
Cx43 would show an increased function compared to wildtype was not fully supported,
since only one Cx40 mutant allele was required to cause disease, L221I/Cx40 heteromeric
hemichannels still showed an apparent gain-of-function. In previous studies, a gain in
hemichannel function has been shown to play a role in inherited diseases with connexin
mutations. Cx30 mutants, G11R and A88V, linked to Clouston syndrome, which is a form
of ectodermal dysplasia, maintained GJ function with increased hemichannel function in
vitro. Under physiological conditions, ATP-release via hemichannels was observed
compared to wildtype (Essenfelder et al., 2004). Other mutants in Cx32, linked to X-linked
Charcot-Marie-Tooth (CMTX) disease, were also shown to have alterations in
hemichannel activity. S85C, a Cx32 mutant, showed hemichannel-mediated large voltage
dependent currents unlike the wildtype, and F235C, have leaky hemichannels that is linked
to a neuropathy (Abrams et al., 2002; Liang et al., 2005). Cx43 mutations involved in
oculodentodigital dysplasia (ODDD), such as G138R, were also found to show increases
in hemichannel activities (Dobrowolski et al., 2007). It is evident that mutations that lead
to a gain of hemichannel function provide a pathology for disease.
A gain in hemichannel function can provide a number of ways to make the heart prone to
arrhythmia. 1) If the hemichannels prematurely opened, Na+ and K+ would flow according
to their concentration gradients. This would result in membrane depolarization away from
the SA node to trigger an ectopic action potential, which may lead to uncoordinated
contraction, and subsequently, that area of the atria will enter into a refractory period which
would make it insensitive to any incoming action potentials from the SA node (Rudy,
2008). 2) ATP would also be released into the extracellular space. ATP would potentially
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bind to purinergic receptors, which subsequently trigger intracellular Ca2+ wave
propagations. Prolonged high amounts of Ca2+ may trigger premature apoptosis, which
could be a potential factor in the onset of AF (Dale, 2008; Ermak and Davies, 2002). 3) As
ions and small molecules are potentially released due to hemichannel opening, critical
metabolites such as NAD+ or ATP (Kar et al., 2012) may also be released which could
prove detrimental to the cardiomyocytes. Although the direct mechanism may be unclear,
this still suggests that the gain-of-function seen for L221I/Cx40 hemichannels is a prime
suspect in the pathogenesis of lone AF.

39

2.5 References
Abrams CK, Bennett MV, Verselis VK, Bargiello TA. 2002. Voltage opens unopposed gap
junction hemichannels formed by a connexin 32 mutant associated with X-linked
Charcot-Marie-Tooth disease. Proc Natl Acad Sci U S A 99:3980-3984.
Bai D. 2014. Atrial fibrillation-linked GJA5/connexin40 mutants impaired gap junctions
via different mechanisms. FEBS Lett 588:1238-1243.
Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. 1998. Impact
of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation
98:946-952.
Bennett MV, Contreras JE, Bukauskas FF, Saez JC. 2003. New roles for astrocytes: gap
junction hemichannels have something to communicate. Trends Neurosci 26:610617.
Bukauskas FF, Verselis VK. 2004. Gap junction channel gating. Biochim Biophys Acta
1662:42-60.
Clontech Laboratories, Inc. 2009. pBI-CMV1 Vector Information. PR963272. Mountain
View, CA, USA. [Information Sheet]
Dale N. 2008. Dynamic ATP signalling and neural development. J Physiol 586:2429-2436.
De Vuyst E, Decrock E, Cabooter L, Dubyak GR, Naus CC, Evans WH, Leybaert L. 2006.
Intracellular calcium changes trigger connexin 32 hemichannel opening. EMBO J
25:34-44.
Dobrowolski R, Sommershof A, Willecke K. 2007. Some oculodentodigital dysplasiaassociated Cx43 mutations cause increased hemichannel activity in addition to
deficient gap junction channels. J Membr Biol 219:9-17.
Ermak G, Davies KJ. 2002. Calcium and oxidative stress: from cell signaling to cell death.
Mol Immunol 38:713-721.
Essenfelder GM, Bruzzone R, Lamartine J, Charollais A, Blanchet-Bardon C, Barbe MT,
Meda P, Waksman G. 2004. Connexin30 mutations responsible for hidrotic
ectodermal dysplasia cause abnormal hemichannel activity. Hum Mol Genet
13:1703-1714.
Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le
Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S.
2006. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial
fibrillation-executive summary: a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines and the
European Society of Cardiology Committee for Practice Guidelines (Writing
Committee to Revise the 2001 Guidelines for the Management of Patients with
Atrial Fibrillation). Eur Heart J 27:1979-2030.
Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. 2001.
Prevalence of diagnosed atrial fibrillation in adults: national implications for
rhythm management and stroke prevention: the AnTicoagulation and Risk Factors
in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370-2375.
Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, Shao Q, Liu X, Veinot JP, Tang
AS, Stewart AF, Tesson F, Klein GJ, Yee R, Skanes AC, Guiraudon GM, Ebihara
L, Bai D. 2006. Somatic mutations in the connexin 40 gene (GJA5) in atrial
fibrillation. N Engl J Med 354:2677-2688.

40

Goodenough DA, Paul DL. 2003. Beyond the gap: functions of unpaired connexon
channels. Nat Rev Mol Cell Biol 4:285-294.
Goodenough DA, Paul DL. 2009. Gap junctions. Cold Spring Harb Perspect Biol
1:a002576.
He DS, Jiang JX, Taffet SM, Burt JM. 1999. Formation of heteromeric gap junction
channels by connexins 40 and 43 in vascular smooth muscle cells. Proc Natl Acad
Sci U S A 96:6495-6500.
Kar R, Batra N, Riquelme MA, Jiang JX. 2012. Biological role of connexin intercellular
channels and hemichannels. Arch Biochem Biophys 524:2-15.
Liang GS, de Miguel M, Gomez-Hernandez JM, Glass JD, Scherer SS, Mintz M, Barrio
LC, Fischbeck KH. 2005. Severe neuropathy with leaky connexin32 hemichannels.
Ann Neurol 57:749-754.
Rudy Y. 2008. Molecular basis of cardiac action potential repolarization. Ann N Y Acad
Sci 1123:113-118.
Severs NJ, Bruce AF, Dupont E, Rothery S. 2008. Remodelling of gap junctions and
connexin expression in diseased myocardium. Cardiovasc Res 80:9-19.
Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, Matsushita T, Kaba R,
Halliday D. 2001. Immunocytochemical analysis of connexin expression in the
healthy and diseased cardiovascular system. Microsc Res Tech 52:301-322.
Sohl G, Willecke K. 2004. Gap junctions and the connexin protein family. Cardiovasc Res
62:228-232.
Sun Y, Hills MD, Ye WG, Tong X, Bai D. 2014. Atrial fibrillation-linked germline
GJA5/connexin40 mutants showed an increased hemichannel function. PLoS One
9:e95125.
Sun Y, Yang YQ, Gong XQ, Wang XH, Li RG, Tan HW, Liu X, Fang WY, Bai D. 2013.
Novel germline GJA5/connexin40 mutations associated with lone atrial fibrillation
impair gap junctional intercellular communication. Hum Mutat 34:603-609.
Thomas T, Telford D, Laird DW. 2004. Functional domain mapping and selective transdominant effects exhibited by Cx26 disease-causing mutations. J Biol Chem
279:19157-19168.
Wolf PA, Abbott RD, Kannel WB. 1991. Atrial-fibrillation as an independent risk factor
for stroke - The Framingham-study. Stroke 22:983-988.
Yang YQ, Liu X, Zhang XL, Wang XH, Tan HW, Shi HF, Jiang WF, Fang WY. 2010.
Novel connexin40 missense mutations in patients with familial atrial fibrillation.
Europace 12:1421-1427.

41

Chapter 3: Functional study of a novel autosomal dominant atrial fibrillationlinked GJC1/connexin45 mutant
3.1 Introduction
Gap junction (GJ) channels are responsible for the direct communication between apposed
cells. Various ions and small metabolites less than 1 kDa in size are able to pass through
these intercellular channels. GJ channels are formed by the head-to-head docking of
hemichannels (HC), which are contributed by apposed cells. HCs are hexamers of
tetraspanning intergral membrane proteins known as connexins (Evans and Martin, 2002;
Goodenough and Paul, 2009). There are 21 genes in the human genome and 20 genes in
mouse genome that encode these connexins (Sohl and Willecke, 2004).
In the heart, connexin45 (Cx45) is abundantly expressed in the sinoatrial (SA) and
atrioventricular (AV) nodes, without other connexins. Cx45 is also expressed in the bundle
of His, upper and lower bundle branches, and Purkinje fibres together with Cx40 and Cx43
(Severs et al., 2008). Action potential propagation from the SA node must travel through
the atria to get to the AV node and from there it will travel through the ventricular
conduction system to the ventricles. It is very likely that Cx45 hemichannels will dock with
either Cx40 or Cx43 to form heterotypic GJ channels in order to propagate the action
potentials from the SA node to the atria.
The importance of Cx45 has been shown in a number of mouse studies. Cx45 knockout
mice are not viable since they die as early as E9.5 due to impairments in the formation of
blood vessels and smooth muscle (Kruger et al., 2000). Cx45 has also been shown to be
highly expressed throughout the heart during development, but during the maturation,

42

Cx45 expression is gradually reduced and localized into the SA and AV nodes, and the
ventricular conduction system; low levels of Cx45 are detectable in both adult atria and
ventricles (Alcolea et al., 1999). Cardiomyocyte-restricted Cx45-knockout mice were
shown to be viable but showed a significant increase in AV conduction delay as implicated
by its ECG and intracardiac measurements (Frank et al., 2012).
Atrial fibrillation is a common cardiac arrhythmia that affects approximately 1% of the
Canadian and American population (Fuster et al., 2006). By 2050 there will almost be a
tripling in the number of cases of AF, which will increase the burden on the healthcare
system (Go et al., 2001). Patients suffering from AF are typically twice as likely to die or
six times as likely to experience stroke (Wolf et al., 1991). Based on the ECG parameters
of patients with AF, they typically show an erratic pattern instead of a strong P-wave, which
suggests uncoordinated activation and ineffective atrial contraction (Wakili et al., 2011).
In approximately 70% of the cases, AF is secondary to other systemic disorders or diseases
such as diabetes, hypertension, myocardial infarction, or coronary artery diseases
(Benjamin et al., 1998). However, in the remaining 30% of cases, AF is a primary disease,
which is called idiopathic or lone AF.
A novel Cx45 mutant, M235L, was found in a lone AF patient, which was autosomal
dominantly inherited in the patient’s family. This is the first case of a Cx45 mutation being
linked to AF. We hypothesize that M235L will show impaired GJ function and impaired
coupling compared to wildtype Cx45.
My data indicated that Cx45 M235L GJs showed significantly reduced GJ coupling when
expressed alone or heterotypically with wildtype Cx43 (or Cx45) suggesting that the
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impairment of GJ function by M235L may be a main factor in predisposing the mutant
carriers to AF.
3.2 Methods
3.2.1 Plasmid construction
The human Cx45-IRES-GFP construct was generated by subcloning human Cx45 (in
pBluescriptII SK(+) vector [generously provided by Dr. Eric Beyer]) into pIRES2-EGFP
between SacI and EcoRI sites. The Cx45 sequence was checked and corrected where
necessary. Cx43-IRES-DsRed was generated by subcloning Cx43 from Cx43-IRES-GFP
vector into the pIRES-DsRed vector between EcoRI and BamHI sites. Cx45-IRES-DsRed
was generated by subcloning Cx45 from Cx45-IRES-GFP vector into pIRES2-DsRed2
vector between SacI and EcoRI sites. The Cx45-IRES-GFP vector was used as a template
to generate the untagged individual point mutant, M235L-IRES-GFP, with the
QuikChange site directed mutagenesis kit (Stratagene, La Jolla, CA) with the following
primers:
Forward - 5’-CTTCCTTCTGATATTGTATGGTGTTACAGGC-3’
Reverse - 5’GCCTGTAACACCATACAATATCAGAAGGAAG-3’
All connexin clones were sequenced to confirm the accuracy of the nucleotide sequence
with no additional variations being introduced.
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3.2.2 Cell culture and transfection
HeLa and N2A (human cervical carcinoma and mouse neuroblastoma cells, respectively,
American Type Culture Collection, Manassas, VA) cells were used. Related methodology
is described in Chapter 2. In addition, approximately 24 hours after transfection N2A cells
were replated on glass coverslips for 2-3 hours prior to electrophysiological recording, and
24 hours after transfection HeLa cells used in the dye uptake assay.
3.2.3 Electrophysiological recording
The Vj-gating property of cell pairs expressing either Cx45 or its mutant, M235L, was
measured by dual whole-cell voltage-clamp technique as described earlier (Bai et al., 2006;
Tong et al., 2014; Xin et al., 2010). The glass coverslips were transferred to a recording
chamber on an inverted microscope (Leica DM IRB, Wetzlar, Germany) filled with
extracellular fluid (ECF) at room temperature (22 – 25oC). The composition of ECF is (in
mM): 135 NaCl, 2 CsCl, 2 CaCl2, 1 MgCl2, 1 BaCl2, 10 HEPES, 5 KCl, 5 D-(+)-glucose,
2 Sodium pyruvate, pH 7.2, ~310 mOsm. GFP-positive and DsRed-positive paired cells
were patched by two glass micropipettes (pipette resistance 2 - 4 MΩ) which were filled
with intracellular fluid (ICF) containing (in mM): 130 CsCl, 10 EGTA, 0.5 CaCl2, 3
MgATP, 2 Na2ATP, 10 HEPES, pH 7.2, ~290 mOsm. Isolated cell pairs were selected to
test Vj-gating. One cell of the pair was clamped at 0 mV while the apposed cell was
administrated with a series of voltage pulses given by a protocol e.g. Voltage pulses of ±20
mV to ±100 mV in 20 mV increments for 7 seconds per pulse. The junctional currents (Ijs)
were amplified by two Axopatch 200B amplifiers (Molecular Devices, Sunnyvale, CA)
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with a low-pass filter (cut-off frequency 1 kHz) and digitalized at a 10 kHz sampling rate
via an ADDA converter (Digidata 1322A, Molecular Devices, Sunnyvale, CA).
3.2.4 Dye uptake assay
Methodology was previously described in Chapter 2. For each experiment approximately
40–50 cells were counted to obtain a percentage of PI-uptake. The bar graphs were
generated with 3–9 transfections.
3.2.5 Statistical analysis
Methodology was previously described in Chapter 2. In addition, Fischer’s exact test was
used to compare the coupling probability of two groups of data, as specified.
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3.3 Results
3.3.1 Homotypic M235L showed impaired gap junction coupling and function
The GJ function of the Cx45 mutant, M235L, was examined through the use of the dual
whole-cell patch clamp technique. Cell pairs expressing M235L were found to have no
transjunctional current (Ij) in response to a Vj-pulse (Fig. 3.1A), which were different from
cell pairs expressing wildtype Cx45. The calculated transjunctional conductance (Gj) of
this mutant was zero (n = 17, N = 6, p < 0.001, one-way ANOVA), which was significantly
different from that of wildtype Cx45 (Gj = 9.8 ± 3.6 nS, n = 14, N = 8). In addition, the
coupling probability seen for M235L (0/17 cell pairs showed coupling) was significantly
less compared to wildtype Cx45 (10/14 cell pairs showed coupling, p < 0.001, Fischer’s
exact test) (Fig. 3.1). Homotypic Cx45 GJs were very sensitive to changes in Vj as it
showed strong gating even at ± 20 mV Vjs (Fig. 3.2).
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Figure 3.1 Gap junctional conductance of homotypic M235L and Cx45 gap junction
channels. (A) Dual whole-cell patch clamp technique was used to measure transjunctional
current (Ij) for homotypic cell pairs of Cx45 and M235L (B) Only 10 out of 14 cell pairs
showed coupling for Cx45 cell pairs. A mean Gj of 9.8 ± 3.6 nS (n = 14, N = 8) was
observed. No cell pairs showed coupling for the homotypic pair of Cx45 mutant, M235L.
M235L also showed significantly reduced Gj (0 nS, n = 17, N = 6, p < 0.001, one-way
ANOVA). The number of transfections (N) are shown above or in the bars. Asterisks
represent statistical significance: ***, p < 0.001
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Figure 3.2 Representative macroscopic gating of homotypic Cx45 gap junction
channels. Macroscopic transjunctional currents (Ijs) from cell pairs of homotypic Cx45
were shown in response to the Vj-protocol. Symmetric gating can be observed.
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3.3.2 M235L showed impaired heterotypic coupling and function with connexin45
Since M235L is predicted to be co-expressed with wildtype Cx45, this mutant may dock
with wildtype Cx45. To study the functional status of M235L/Cx45 GJ channels, the dual
whole-cell patch clamp method was used in cell pairs expressing M235L-IRES-GFP in one
cell and Cx45-IRES-DsRed in the other cell. M235L/Cx45 cell pairs were found to have
no transjunctional current (Ij) in response to a Vj-pulse (Fig. 3.3A), while substantial Ijs
were recorded in cell pairs expressing wildtype Cx45-IRES-GFP in one cell and Cx45IRES-DsRed in the other cell. The calculated transjunctional conductance (Gj) of this
M235L/Cx45 cell pair was zero (n = 15, N = 4), which was significantly lower than that of
wildtype Cx45 (Gj = 2.4 ± 1.1 nS, n = 15, N = 4, p < 0.01, one-way ANOVA). In addition,
the coupling probability seen for M235L/Cx45 (0/15 cell pairs showed coupling) was
significantly less compared to wildtype Cx45/Cx45 (8/15 cell pairs showed coupling, p <
0.01, Fischer’s exact test) (Fig. 3.3).
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Figure 3.3 Gap junctional conductance of heterotypic M235L/Cx45 gap junction
channels. (A) Dual whole-cell patch clamp technique was used to measure transjunctional
current (Ij) for homotypic and heterotypic cell pairs of Cx45 and M235L/Cx45,
respectively (B) Only 8 out of 15 cell pairs showed coupling for Cx45 cell pairs. A mean
Gj of 2.4 ± 1.1 nS (n = 15, N = 4) was observed. No cell pairs showed coupling for
heterotypic cell pairs of M235L/Cx45. M235L/Cx45 also showed significantly reduced Gj
(0 nS, n = 15, N = 4, p < 0.01, one-way ANOVA). The number of transfections (N) are
shown above or in the bars. Asterisks represent statistical significance: **, p < 0.01
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3.3.3 M235L showed impaired heterotypic gap junction coupling and function with
connexin43
In addition to interacting with itself or Cx45, the mutant may form heterotypic GJ channels
with Cx43 in the atria. To test this heterotypic GJ function, I measured Ijs in cell pairs with
one cell expressing M235L-IRES-GFP and the other cell expressing Cx43-IRES-DsRed.
M235L/Cx43 cell pairs were found to have very little Ij in response to a Vj-pulse (Fig.
3.4A), while much higher Ijs were recorded in cell pairs expressing wildtype Cx45-IRESGFP in one cell and Cx43-IRES-DsRed in the other cell. The Gj of the M235L/Cx43 cell
pair was significantly lower (0.03 ± 0.03 nS, n = 14, N = 6) than Cx45/Cx43 cell pairs
(13.5 ± 5.2 nS, n = 13, N = 8, p < 0.01, Student’s t-test). In addition, the coupling probability
seen for M235L/Cx43 (2/14 cell pairs showed coupling) was significantly less in
comparison to wildtype Cx45/Cx43 (9/13 cell pairs showed coupling, p < 0.01, Fischer’s
exact test) (Fig. 3.4). Both Cx45/Cx43 and M235L/Cx43 showed strong asymmetric Vjgating, however, M235L/Cx43 has smaller Ijs compared to Cx45/Cx43 (Fig. 3.5).
3.3.4 M235L expressing cells showed no alteration in propidium iodide uptake
The dye uptake assay was done with PI as the dye of interest in DCF conditions in HeLa
cells to assess any potential hemichannel function of this Cx45 mutant. Very little PI uptake
was observed for both the wildtype Cx45 and the mutant, M235L (Fig. 3.6A). There was
no difference in PI uptake of M235L (3.1 ± 1.0%, N = 6) compared to Cx45 (5.7 ± 2.4%,
N = 6, p > 0.05, Student’s t-test) (Fig. 3.6B), indicating no apparent difference in this Cx45
mutant, M235L, in PI uptake.
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Figure 3.4 Gap junctional conductance of heterotypic M235L/Cx43 gap junction
channels. (A) Dual whole-cell patch clamp technique was used to measure transjunctional
current (Ij) for heterotypic cell pairs of Cx45/Cx43 and M235L/Cx43. (B) Only 9 out of 13
cell pairs showed coupling for Cx45/Cx43 cell pairs. A mean Gj of 13.5 ± 5.2 nS (n = 13,
N = 8) was observed. 2 out of 14 cell pairs showed coupling for the heterotypic cell pairs
of M235L/Cx43. M235L/Cx43 also showed significantly reduced Gj (0.03 ± 0.03 nS, n =
14, N = 6, p < 0.01, Student’s t-test). The number of transfections (N) are shown above or
in the bars. Asterisks represent statistical significance: **, p < 0.01
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Figure 3.5 Representative macroscopic gating traces of heterotypic Cx45/Cx43 and
M235L/Cx43 gap junction channels. Macroscopic transjunctional currents (Ijs) from cell
pairs of heterotypic Cx45/Cx43 and M235L/Cx43 were shown in response to the Vjprotocol. Smaller macroscopic gating can be observed in M235L/Cx43 relative to
Cx45/Cx43. Asymmetric gating can be observed for both Cx45/Cx43 and M235L/Cx43.
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Figure 3.6 PI uptake of HeLa cells expressing Cx45 mutant, M235L, in DCF
conditions. (A) Representative PI uptake images of cells expressing Cx45 mutant, M235L.
Little PI uptake was observed. Column 1 shows GFP fluorescence. Column 2 shows cells
with PI uptake in red. Column 3 is an overlay, which is the combination of green and red
fluorescence. Column 4 displays a phase contrast image of HeLa cells. Scale bars in each
series of images are represented as 20 µm. (B) Graph summarizing PI uptake of cells
expressing Cx45 mutant, M235L, wildtype Cx45, the positive control, Cx26, and the
negative control, GFP. No significance (ns) was observed comparing cells expressing
M235L with the wildtype. The number of transfections (N) is denoted by the numbers on
the bars.
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3.4 Discussion
This is the first study of a Cx45 mutation linked to AF. Both atria-enriched connexins,
Cx40 and Cx43, have been shown to have mutations linked to early onset of AF. (Bai,
2014; Molica et al., 2014; Severs et al., 2008; Thibodeau et al., 2010). It would be
interesting to characterize this Cx45 mutant in order to elucidate any potential mechanisms
that may predispose the mutant carriers to AF.
The dual whole-cell patch clamp technique was used to study the GJ channel function of
the Cx45 mutant, M235L. Cell pairs with homotypic M235L GJs revealed that there was
no GJ channel function compared to wildtype Cx45. Since M235L is an autosomal
dominant mutation, one gene allele is enough to link disease; the other gene allele would
still be wildtype Cx45. It is possible that in the nodal cells of the atria, that M235L can
heterotypically dock with Cx45. In studying this, heterotypic M235L/Cx45 GJ channels
showed no Gj which would suggest that no functional heterotypic M235L/Cx45 GJ
channels were formed. In addition to docking with other Cx45-expressing nodal cells, it
may be possible for the nodal cells to dock with the cardiomyocytes of the atria since the
action potentials from the SA node must propagate through the atria to trigger contraction.
Since the atria co-expresses Cx40 and Cx43 (Severs et al., 2008), it is possible for M235L
to dock with either Cx40 and/or Cx43. The heterotypic GJ channel function of M235L and
Cx43 was studied, which revealed virtually no conductance similar to the negative controls,
and significantly lower than the conductance of Cx45/Cx43 GJ channels. Since Cx45/Cx40
showed no GJ channel function (see Chapter 4) we did not pursue a full functional study
of M235L/Cx40 GJs. Future studies may look into the heteromeric interactions between
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Cx45 M235L with wildtype Cx45 and the heterotypic GJ channels of M235L with cells
co-expressing both Cx40 andCx43, as all these GJs are predicted to exist in the heart.
The dye uptake assay was used to study the potential hemichannel function of M235L. AFlinked Cx40 mutants, L221I and V85I, which were previously studied, showed an increase
in PI uptake. This may be due to a gain in hemichannel function, which could play a role
in the pathogenesis of AF (Sun et al., 2014). M235L, however, showed very little PI uptake
and was not statistically different from that of Cx45. However, we could not rule out the
possibility of M235L hemichannels having an altered function when exposed to other
specific stimuli, such as changes in transmembrane potential, mechanical stimulation, or
increased intracellular calcium (Bennett et al., 2003; De Vuyst et al., 2006; Goodenough
and Paul, 2003).
It is unclear as to how impaired Cx45 GJ channel function can lead to AF since this is the
first Cx45 mutant linked to AF. Previous studies regarding AF-linked connexin mutants
generally show an impaired GJ channel function, such as the Cx40 mutants studied by
Gollob et al., in 2006. One of the mutants, P88S, was a somatic mutation found in the atria
of two patients. It showed an impaired GJ channel function compared to wildtype Cx40
(Gollob et al., 2006). Another AF-linked Cx40 mutant, I75F, which is a germline
autosomal dominant mutation, has also showed impaired GJ channel function (Sun et al.,
2013). It has been implicated that impaired GJ channel function in the atria introduces
increased heterogeneity and reduced conduction velocity, which could be substrates for AF
(Bai, 2014; Wakili et al., 2011). A similar instance of this may involve the nodal regions
of the heart, which may contribute to AF.
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Work with Cx45 knockout mice have been performed in previous studies. In general, Cx45
knockouts are not viable between E9.5 and E10.5 due to impaired blood vessel formation
and smooth muscle development (Kruger et al., 2000). As such, cardiomyocyte-restricted
Cx45 knockout mice were used to study the role of Cx45 in the heart. Mice lacking Cx45
in the heart showed no change in resting heart rate and no spontaneous arrhythmia,
however, mice also express Cx30.2 and Cx40 at their nodes, which may compensate for
the loss of Cx45 to some degree. Humans, however, do not express the Cx30.2 equivalent,
Cx31.9, or Cx40 at their nodes, which may differ from what was observed in mice
(Kreuzberg et al., 2009). Mice heterozygous for Cx45 showed strong Cx45 expression in
cardiac tissues and they were viable enough to breed, but in Cx40 knockout mice, however,
heterozygous expression of Cx45 exacerbated the issues seen in Cx40 knockouts (Frank et
al., 2012; Kruger et al., 2006). This suggests that there may be some interplay between
Cx40 and Cx45 regarding proper action potential propagation. Cx45 has been
demonstrated to be critical in development and may also play a role in the maintaining
proper cardiac conduction. As patients with M235L have been shown to develop AF it will
be interesting to see directly how the impairment of GJ channel function of Cx45 can lead
to AF in humans.
During development, Cx45 is highly expressed throughout the heart. In the adult heart,
however, Cx45 expression is reduced and localized in specific regions such as the SA and
AV nodes, and the ventricular conduction system. During development, it may be possible
for Cx45 and Cx40 (or Cx43) to interact in the atria (Alcolea et al., 1999). As the Cx45
mutant, M235L, showed no transjunctional coupling in homotypic cell pairs or heterotypic
cell pairs with Cx43 (and possibly Cx40) it may be possible for M235L to exert a dominant-
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negative effect on Cx43 (and Cx40). Other AF-linked mutants such as I75F, showed no
transjunctional coupling conductance and exhibited dominant-negative effects on Cx43
(and Cx40) (Sun et al., 2013). Future studies may serve to identify whether or not M235L
exhibits dominant-negative effects on Cx43 (and Cx40) and how that may play a role in
the development of AF.
To conclude, M235L, a germline autosomal dominant Cx45 mutation, was recently
discovered and is the first Cx45 mutation linked to AF. M235L did not show GJ channel
function when expressed in cell pairs. No functional couplings were observed when M235L
expressing cells paired with wildtype Cx45 or Cx43 expressing cells. These impairments
in Cx45 mutant-containing GJs may alter the functional coupling in/near the SA node and
possibly in the atria to lead to AF. In addition, it is clear that Cx45 plays a major role in
cardiac development and cardiac conduction.
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Chapter 4: Engineered connexin40 variant improves docking and function to
connexin43 and connexin45
4.1 Introduction
The connexin (Cx) is a tetraspanning integral membrane protein. 12 connexin subunits
comprise a single gap junction (GJ) channel and spans both membranes of apposed cells
(Goodenough and Paul, 2009). There are 21 genes in the human genome and 20 genes in
the mouse genome encoding connexins (Sohl and Willecke, 2004). Connexins oligomerize
into a hexamer to form hemichannels (HCs). HCs from apposing cells dock head-to-head
by non-covalent interactions, including hydrogen bonds, in order to form full GJ channels.
Since many tissues express more than one connexin isoform, it is possible for different
connexin isoforms to oligomerize together to form heteromeric HCs; this is in addition to
forming homomeric HCs which are composed of the same connexin isoform. It is also
possible to have two different homomeric HCs from apposing cells to dock with one
another to form homomeric heterotypic GJ channels (Goodenough and Paul, 2009).
In the heart, specifically in the atria, Cx40 and Cx43 are co-expressed, while Cx45 is
enriched in the SA and AV nodes. This presents the possibility to form heterotypic GJ
channels such as Cx40/Cx43 in the atria, or Cx40/Cx45 and Cx45/Cx43 at the border
between atrial and nodal cells (Severs et al., 2008). Previous studies regarding the
heterotypic compatibility between Cx40 and Cx43 revealed contradictory conclusions;
some studies suggest that Cx40/Cx43 heterotypic GJ channels are functional whereas other
studies suggest otherwise (Bruzzone et al., 1993; Lin et al., 2014; Rackauskas et al., 2007;
Valiunas et al., 2000). Studies involving the heterotypic compatibility between murine
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Cx40 and Cx45 revealed that these connexins were co-localized, and showed functional
channels with asymmetric gating, which suggest Cx40 and Cx45 are compatible to form
heterotypic GJ channels (Coppen et al., 1998; Elfgang et al., 1995; Rackauskas et al.,
2007), however, no study was performed on the heterotypic compatibility between human
Cx40 and Cx45.
In 2009, the first high resolution crystal structure of a human Cx26 GJ channel was
resolved. Numerous hydrogen bonds (HBs) were revealed at the extracellular docking
interface which suggest that HBs play an important role in the docking of HCs to form
functional GJ channels (Maeda et al., 2009). The role of HBs in HC docking was also
examined by studying the heterotypic docking between Cx26 and Cx32. Disease-linked
mutations of Cx32 on the extracellular domain reduced the number of available HBs, which
impaired GJ function and plaque formation. This, however, was rescued by introducing
structurally complementary mutations in Cx26 which increased the number the HBs. The
increase in HBs by introducing these mutations in Cx26 was able to restore GJ function
(Gong et al., 2013). It is unknown if the heterotypic docking between human Cx40 and
Cx43 or Cx40 and Cx45 are able to form functional heterotypic GJ channels.
Sequence alignment of Cx40, Cx43, Cx45, and Cx26 was performed. Many amino acid
residues appeared to be well-conserved in these connexins, in particular at the extracellular
domains, which suggests that the Cx26 crystal structure could be used as a template to
develop homology models in these cardiac connexins. By using the homology models, the
HB sites suspected to be involved in docking were revealed in the extracellular domains,
one of which was the amino acid residue at the position 54 on Cx26. On Cx40, the
corresponding position is 55. Aspartic acid (D) is present in Cx40, which differs from
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asparagine (N) which is found in Cx43 and Cx45 (Bai and Wang, 2014). It is possible that
this is a critical residue in the docking between Cx40 and Cx43 as well as Cx40 and Cx45.
We hypothesize that Cx40, Cx43, and Cx45 GJ channels possess similar structures at the
docking interface as Cx26 and use similar residues for docking. The mutation in the Cx40
E1 domain, D55N, which makes Cx40 similar in the residues found in Cx43 and Cx45,
will increase the heterotypic docking of Cx40/Cx43 and Cx40/Cx45.
For this study we generated a Cx40 variant, D55N, based on the model of docking
compatibility by using the structure of Cx26 as a template. D55N was used to form
heterotypic GJ channels with Cx43 and Cx45, and was able to increase GJ conductance
when paired with Cx43 or Cx45 compared to heterotypic GJ channels formed by wildtype
Cx40/Cx43 or Cx40/Cx45. This study suggests that the structural model of Cx26 was an
excellent template to develop homology models for cardiac GJ channels and was able to
help up design a proper variant to increase docking compatibility between different
connexins.
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4.2 Methods
4.2.1 Plasmid construction
The human Cx40-IRES-GFP construct was created as previously described in Chapter 2.
Cx43-IRES-DsRed and Cx45-IRES-DsRed were created as previously described in
Chapter 3. The Cx40-IRES-GFP vector was used as a template to generate the untagged
individual point mutant, D55N-IRES-GFP, with the QuikChange site directed mutagenesis
kit (Stratagene, La Jolla, CA) with the following primers:
Forward - 5’-GATTTCCGGTGTAATACGATTCAGCC-3’
Reverse - 5’-GGCTGAATCGTATTACACCGGAAATC-3’
All connexin clones were sequenced to confirm the accuracy of the nucleotide sequence
with no additional variations being introduced.
4.2.2 Cell culture and transfection
Methodology was previously described in Chapter 2 Approximately 24 hours after
transfection N2A cells were replated on glass coverslips for 2-3 hours prior to
electrophysiological recording.
4.2.3 Electrophysiological recording
Methodology was previously described in Chapter 3.
4.2.4 Statistical analysis
Methodology was previously described in Chapter 2.
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4.3 Results
4.3.1 Heterotypic Cx40 D55N/Cx43 showed an increased gap junctional coupling
conductance than Cx40/Cx43
Based on the structural model of Cx26, the variant of Cx40, D55N, was designed and
engineered in an attempt to improve heterotypic docking to Cx43. Cell pairs with one cell
expressing Cx40 and the other cell expressing Cx43 showed very little transjunctional
conductance (Gj) (0.2 ± 0.2 nS, n = 20, N = 5). However, cells expressing the Cx40 variant,
D55N, were well-coupled to Cx43 expressing cells with a significantly higher Gj (7.1 ± 3.6
nS, n = 15, N = 4, p < 0.05, Student’s t-test) (Fig. 4.1).
Representative transjunctional currents (Ijs) of Cx40/Cx43 and D55N/Cx43 heterotypic
gap junctions in response to a series of Vj-pulses show a stark contrast in the current
amplitudes. At 10x zoom into the Ijs Cx40/Cx43 heterotypic GJs, apparent unitary channel
currents could be observed (Fig. 4.2). Rapid Vj-gating was observed when D55N cells were
pulsed with +Vj (or -Vj for the Cx43 expressing cell). When the opposite Vj was applied to
D55N, a slower Vj-gating was displayed (Fig. 4.2).
Because of the significant increase in Gj, this would suggest an improvement in heterotypic
docking with Cx43. It appears that the use of Cx26 as a structural model was helpful for us
in designing a variant to improve Cx40/Cx43 heterotypic docking.

67

A

20 mV
0 mV 0.1 nA 2 s

Vj
Cx40
Cx43

D55N
Cx43

Ij

Conductance (nS)

B

15

*

10

5
N=7
0/17

N=5
6/20

- Control

Cx40
Cx43

N=4
9/15

0
D55N
Cx43

Figure 4.1 Gap junctional conductance of heterotypic D55N and Cx43 gap junction
channels. (A) Dual whole-cell patch clamp technique was used to measure transjunctional
current (Ij) for heterotypic cell pairs of Cx40/Cx43 and D55N/Cx43 (B) Only 6 out of 20
cell pairs showed coupling for Cx40/Cx43 heterotypic cell pairs. Small Gj (0.2 ± 0.2 nS, n
= 20, N = 5) was observed. 9 out of 15 cell pairs showed coupling for the heterotypic pair
of Cx40 variant, D55N, with Cx43. D55N/Cx43 also showed significantly higher Gj (7.1
± 3.6 nS n = 15, N = 4, p < 0.05, Student’s t-test). The number of transfections (N) are
shown above or in the bars. Asterisks represent statistical significance: *, p < 0.05
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Figure 4.2 Representative macroscopic gating traces of heterotypic Cx40/Cx43 and
D55N/Cx43 gap junction channels. Macroscopic transjunctional currents (Ijs) from cell
pairs of heterotypic Cx40/Cx43 and D55N/Cx43 were shown in response to the Vjprotocol. Small macroscopic gating can be observed in Cx40/Cx43. A box zoomed in at
10x shows that Cx40/Cx43 traces are mostly single or multi-channel activities.
Asymmetric gating can be observed for D55N/Cx43.
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4.3.2 Heterotypic Cx40 D55N/Cx45 showed an increased gap junctional coupling
conductance than heterotypic Cx40/Cx45
To study heterotypic docking of human Cx40 and Cx45, we mixed cells expressing Cx40
with cells expressing Cx45 and then studied heterotypic cell pairs with the dual whole-cell
patch clamp method. No transjunctional currents were observed in response to a Vj-pulse
(Fig. 4.3A, n = 20, N = 8), indicating that heterotypic Cx40/Cx45 GJs were not functional
possibly due to an incompatibility at the docking interface. The introduction of the Cx40
variant, D55N, was used to determine if it may be responsible for the heterotypic
incompatibility. When Cx40 D55N expressing cells were paired with Cx43 expressing
cells, Ijs were significantly increased in response to the same Vj-pulse (Fig 4.3). Gj was
plotted, and was significant increased (9.9 ± 3.5 nS, n = 17, N = 6, p < 0.01, Student’s ttest) compared to Cx40/Cx45 cell pairs (Fig. 4.3). Asymmetric Vj-gating was also observed
as shown in the representative macroscopic trace (Fig. 4.4).
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Figure 4.3 Gap junctional conductance of heterotypic D55N and Cx45 gap junction
channels. (A) Dual whole-cell patch clamp technique was used to measure transjunctional
current (Ij) for heterotypic cell pairs of Cx40/Cx45 and D55N/Cx45 (B) Only 2 out of 20
cell pairs showed coupling for Cx40/Cx45 heterotypic cell pairs. No Gj was observed
overall. 11 out of 17 cell pairs showed coupling for the heterotypic docking of the Cx40
variant, D55N with Cx45. D55N/Cx45 also showed significantly higher Gj (9.9 ± 3.5 nS,
n = 17, N = 6, p < 0.01, Student’s t-test). The number of transfections (N) are shown above
or in the bars. Asterisks represent statistical significance: **, p < 0.01
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Figure 4.4 Representative macroscopic gating trace of heterotypic D55N/Cx45 gap
junction channels. Macroscopic transjunctional current (Ijs) from a cell pair of heterotypic
D55N/Cx45 was shown in response to the Vj-protocol.
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4.4 Discussion
The premise for this study was to use the structural model of Cx26 as a template to predict
the contribution of equivalent residues in cardiac connexins responsible for heterotypic
docking compatibility. Sequence alignment revealed an odd docking-relevant residue in
the Cx40 D55 position as the corresponding position in all other connexins is Asn (N). In
the heterotypic docking of Cx40/Cx43 and Cx40/Cx45, a Cx40 variant, D55N, was
engineered in an attempt to improve docking compatibility. This position was predicted to
be involved in forming a docking HB (Bai and Wang, 2014), of which, HBs in general
were shown to be critical in the docking of HCs to form functional GJ channels (Gong et
al., 2013; Maeda et al., 2009).
This study revealed that a majority of heterotypic Cx40/Cx43 cell pairs showed no
coupling, which was similar to a number of previous studies, which suggested that
Cx40/Cx43 GJ channels were non-functional (Bruzzone et al., 1993; Elfgang et al., 1995;
Rackauskas et al., 2007).
In the present study on human Cx40/Cx45 heterotypic cell pairs, no functional coupling
was observed, which was opposite of what was seen for murine Cx40/Cx45 heterotypic
cell pairs (Elfgang et al., 1995; Rackauskas et al., 2007). Two possible reasons exist that
may explain this observation. Firstly, sequence alignment of human Cx40 and murine Cx40
revealed a few differences in the NT, TM1, TM3, TM4, CL, and CT. These differences
may have an indirect effect on the structure at the docking interface. Sequence alignment
of human and murine Cx45 revealed a 97% homology, with differences only in CL and
CT, which is unlikely to play an important role in the structure of the docking interface.
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Secondly, previous studies used HeLa cells to express their connexins as opposed to N2A
cells, which were used in this study (Elfgang et al., 1995; Rackauskas et al., 2007). In our
lab, HeLa cells were shown to have low background coupling conductance from time to
time (Tong and Bai, unpublished observation). It is possible that the background coupling
conductance of HeLa cells contributed to the coupling conductance seen in murine
heterotypic Cx40/Cx45. At present we could not rule out other possibilities or experimental
conductions for this apparent difference.
For both types of heterotypic GJ channels (Cx40/Cx43 and Cx40/Cx45), the introduction
of the Cx40 variant, D55N, increased the GJ conductance (Gj). Overall, these data support
the idea that the Cx40 D55 is an important residue for the heterotypic docking compatibility
in heterotypic Cx40/Cx43 and Cx40/Cx45 docking.
As the Cx40 variant, D55N, improved heterotypic docking to Cx43, detailed Vj-gating
characterization was possible and was shown to be asymmetrical. When the D55N
expressing cell of the heterotypic D55N/Cx43 cell pair was pulsed with +Vj, rapid Vjgating was observed as opposed to being pulsed with -Vj. This was consistent with what
was reported regarding the predicted gating polarity of wildtype murine Cx40 (Gonzalez
et al., 2007). It is possible that the differences in murine and human Cx40 may lead to a
change in Vj-gating polarity, however, the Ijs observed for Cx40/Cx43 are too small to
identify its Vj-gating polarity. It is very likely the introduction of D55N did not alter the
Vj-gating polarity of Cx40, however, future studies may be directed to identifying the V jgating polarity of human Cx40 to determine if that is the case.
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The cardiac action potential propagating from the SA node (mainly expressing Cx45) to
the atria (mainly expressing Cx40 and Cx43) can occur through heterotypic Cx40/Cx45 (or
Cx43/Cx45) GJ channels. In the atria, action potentials could go through heterotypic
Cx40/Cx43 and other GJ channels, and then reaching the AV node (mainly expressing
Cx45) it propagates through Cx40/Cx45 (or Cx43/Cx45) GJ channels. A number of
mutations on Cx40 have led to early onset of atrial fibrillation (Gollob et al., 2006; Sun et
al., 2013). Typically, AF-linked mutants displayed an impairment of GJ function which
may lead to a reduction in conduction velocity to promote reentry and may become a driver
for AF (Wakili et al., 2011). Previous studies performed on Cx40 knockout mice suggested
a reduction in conduction velocity, which may have explained the presence of arrhythmia
that was found in some of the mice (Bagwe et al., 2005; Hagendorff et al., 1999; Kirchhoff
et al., 1998), however, increases in conduction velocity in Cx40 knockout mice were also
found (Beauchamp et al., 2006). Human studies regarding the relationship between Cx40
and conduction velocity have also shown that conduction velocity was inversely
proportional to Cx40 / [Cx40 + Cx43] expression (Kanagaratnam et al., 2002). Regardless,
a decrease or increase in conduction velocity may both play roles in the promotion of
heterogeneity and arrhythmia (Rohr et al., 1997). With this perspective, it is tempting to
speculate that the introduction of D55N may provide more heterotypic compatible GJs for
the propagation of action potentials due to the increased heterotypic coupling in
Cx40/Cx43 and Cx40/Cx45 GJ channels. It is possible that D55N could play a beneficial
role in the heart, however, proper models would be needed to study any effects this
mutation will have in vivo.
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The structural model of Cx26 appeared to be well-suited to identify critical residues
responsible for docking incompatibility such as Cx40/Cx43 and Cx40/Cx45, and to predict
and improve the docking ability of other incompatible connexins. It is possible that the
combination of modeling, mutagenesis, and experimental study of the functional outcomes
of mutant connexins can be done to understand docking compatibility in cardiac or other
connexins.
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Chapter 5: General discussion
5.1 Connexins in atrial fibrillation
The present thesis looked into the functional aspects of three cardiac mutants linked to
atrial fibrillation (AF), Cx40 L221I, V85I, and Cx45 M235L. The Cx40 mutants, L221I
and V85I, were co-expressed with Cx40 (or Cx43) in an attempt to mimic native atrial
tissue expression (Severs et al., 2008), and the cells co-expressing mutant and wildtype had
their hemichannel (HC) function assessed by the dye uptake assay. The Cx45 mutant,
M235L, was the first Cx45 mutant linked to AF, and its gap junction (GJ) function and HC
function were studied. For the Cx40 mutants, only L221I-Cx40 expressing cells showed
more uptake of propidium iodide (PI) compared to wildtype, which suggests that gain of
HC function may link these mutants to AF. In the case for Cx45 M235L, homotypic GJ
(M235L/M235L) and heterotypic GJ (M235L/Cx45 and M235L/Cx43) functions were
significantly reduced, but no alteration in PI uptake was observed under our experimental
conditions. Impairment of Cx45 GJ function could be linked to AF in the mutant carriers,
similar to several other AF-linked Cx40 and Cx43 mutants.
AF is the most common sustained cardiac arrhythmia. AF is usually a secondary disease to
systemic diseases or disorders such as hypertension, diabetes, myocardial infarction, or
cardiomyopathies (Benjamin et al., 1998). In a smaller number of cases, AF without other
cardiovascular diseases is called idiopathic or lone AF (Fuster et al., 2006). AF is
characterized by irregular atrial action potential propagation, mainly caused by reentrant
circuits in clinical cases. If the conduction velocity of action potentials is decreased, this
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could allow reentrant circuits to form. Normally, the conduction velocity is too fast to have
reentry in the atria due to the refractory period (Wakili et al., 2011).
As cells co-expressing Cx40 and L221I showed more PI uptake compared to cells coexpressing two wildtype Cx40, this could be attributed to the gain-of-function seen in
L221I hemichannels. When dye uptake was performed on cells expressing L221I or V85I
alone, significant increases in PI uptake was observed compared to cells only expressing
wildtype Cx40 (Sun et al., 2014). In addition, no apparent impairments in GJ function were
seen for both mutants, which suggest that the increase in HC may be the principal
contributor to AF observed in the mutant carriers (Sun et al., 2014). A number of
mechanisms may exist that could make the cells expressing these mutants more vulnerable
to stress factors, which could lead to cell death and promoting reentry in the atria of the
mutant carriers.
The AF-linked Cx45 mutant, M235L, showed GJ impairment with no obvious alteration
in PI-uptake compared to wildtype Cx45. Since this is the first AF-linked Cx45 mutant, no
comparisons could be made with other AF-linked Cx45 mutants, however there are Cx40
mutants which are similar. Mutations in Cx40 have been linked to AF (Bai, 2014; Molica
et al., 2014), and Cx40 knockout mice have also been shown to have increased vulnerability
to arrhythmia (Kirchhoff et al., 1998), or humans with altered Cx40 / [Cx40 + Cx43] ratios
in the atria (Kanagaratnam et al., 2002). A number of AF-linked Cx40 mutants, such as
I75F or P88S, showed impairment in GJ function, which may be the major contributor to
trigger AF (Gollob et al., 2006; Sun et al., 2013). Impairment in GJ function may reduce
coupling conductance which may lead to a reduction of conduction velocity, a predicted
prerequisite for AF (Wakili et al., 2011). Due to the localized expression in the adult
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myocardium, it is possible that this reduction in coupling conductance could be seen near
the SA or AV nodes of the right atrium.
A summary of what was observed for the AF-linked connexin mutants, L221I, V85I, and
M235L, has been compiled in addition to known AF-linked connexin mutants that were
previously studied (Table 5.1).
5.2 Heterotypic docking and cardiac function
This study also examined the heterotypic docking compatibility between cardiac
connexins, specifically those of Cx40/Cx43 and Cx40/Cx45 (Severs et al., 2008).
Combining the sequence alignment of Cx40, Cx43, Cx45, and Cx26, and the crystal
structure of Cx26, we identified a potential critical residue involved in GJ docking (Bai
and Wang, 2014; Maeda et al., 2009). Mutating this Cx40 residue, D55N was found to be
sufficient to make it capable of docking to Cx43 and Cx45.
Since the atria co-expresses Cx40 and Cx43, with Cx45 enriched in the SA and AV nodes,
heterotypic interactions are a possibility for these connexins (Severs et al., 2008). I predict
that Cx45 in the SA node may form most functional GJ channels with Cx43 and not with
Cx40 due to docking incompatibility. Atrial cardiomyocytes may form homotypic GJs,
heteromeric heterotypic GJs and homomeric heterotypic Cx40/Cx43 GJs. The latter, and
possibly heteromeric heterotypic GJs, may not couple well, but can be improved by the
introduction of Cx40 D55N. Perhaps it is possible to use this variant to increase atrial
coupling and reduce heterogeneity as a novel treatment for AF.
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Table 5.1 Functional status of atrial fibrillation-linked connexin mutants in Cx40,
Cx43, and Cx45
Connexin

AF-linked mutants GJ function?

HC function?

Cx40

G38D, Q49X, I75F, Impairment

Normal (some are

P88S, A96S,

untested)

M163V, L229M

L221I, V85I

Normal

Increased

Cx43

G60S, G138R

Impairment

Increased

Cx45

M235L

Impairment

Normal
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5.3 Limitations and future studies
A majority of this study relied on the dual whole-cell patch clamp method to determine the
GJ function of the many mutants and cell pairs examined. Due to the potential of having
leak current this may underestimate the amount of Ij that passes through GJ channels. In
order to circumvent this I selected cell pairs with high plasma membrane resistance (>500
MΩ, or leak current smaller than 20 pA with a 10 mV Vj-pulse) to improve patch clamp
quality (Van Rijen et al., 1998). I also used Dextran Texas Red (3 kDa), which is a GJ
impermeable dye, to confirm cell pairs with high Gj were not due to cytoplasmic bridges.
The use of the bidirectional vector was important in the study of interactions of coexpressing wildtype Cx40 (or Cx43) with AF-linked Cx40 mutants, L221I or V85I. It is
predicted to be expressed at a 1:1 ratio during biosynthesis. However, we are currently
unaware if these mutants could trigger early degradation pathways to reduce their apparent
steady-state expression levels. A good future experiment may include a Western blot to
confirm the 1:1 expression pattern of this vector at a steady-state expression.
Future studies regarding the Cx45 mutant, M235L, may include assessing any potential
dominant-negative effects the mutant may have heteromeric interaction with Cx45, Cx40,
and Cx43, which could also contribute to the pathogenesis of AF.
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